Cargando…

Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies

BACKGROUND: The association between epidermal growth factor (EGF) gene +61A/G polymorphism (rs4444903) and hepatocellular carcinoma (HCC) susceptibility has been widely reported, but the results were inconsistent. To clarify the effect of this polymorphism on HCC risk, a meta-analysis was performed....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Guoping, Yu, Ke, Shao, Lifang, Yu, Xiaobo, Hu, Chen, Qian, Pei, Xie, Haiyang, Li, Jinjun, Zheng, Jie, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418097/ https://www.ncbi.nlm.nih.gov/pubmed/25927412 http://dx.doi.org/10.1186/s12885-015-1318-6

Ejemplares similares

Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population
por: Gholizadeh, Mehdi, et al.
Publicado: (2017)

TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2017)

A Functional +61G/A Polymorphism in Epidermal Growth Factor Is Associated with Glioma Risk among Asians
por: Xu, Xin, et al.
Publicado: (2012)

Association between the Epidermal Growth Factor +61G/A Polymorphism and Glioma Risk: A Meta-Analysis
por: Chen, Xin, et al.
Publicado: (2014)

A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276
por: Yu, Xiaobo, et al.
Publicado: (2019)

Association between polymorphisms of epidermal growth factor 61 and susceptibility of lung cancer: A meta-analysis
por: Chen, Quan, et al.
Publicado: (2020)

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma
por: Xiao, Fenqiang, et al.
Publicado: (2013)

Single Nucleotide Polymorphisms in the Metastasis-associated in Colon Cancer-1 Gene Predict the Recurrence of Hepatocellular Carcinoma after Transplantation
por: Zheng, Zhiyun, et al.
Publicado: (2014)

SOCS1 blocks G1-S transition in hepatocellular carcinoma by reducing the stability of the CyclinD1/CDK4 complex in the nucleus
por: Ding, Jun, et al.
Publicado: (2020)

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest
por: Zhou, Wei, et al.
Publicado: (2021)

ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression
por: Chen, Cong, et al.
Publicado: (2018)

Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation
por: Yu, Xiaobo, et al.
Publicado: (2014)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Combination of HSP90 and autophagy inhibitors promotes hepatocellular carcinoma apoptosis following incomplete thermal ablation
por: Chen, Fen, et al.
Publicado: (2020)

G Protein-Coupled Receptor 87 (GPR87) Promotes the Growth and Metastasis of CD133(+) Cancer Stem-Like Cells in Hepatocellular Carcinoma
por: Yan, Mingxia, et al.
Publicado: (2013)

The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
por: He, Bin, et al.
Publicado: (2018)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

Recipient Cytotoxic T Lymphocyte Antigen 4 +49 Single-Nucleotide Polymorphism Is Not Associated with Acute Rejection after Liver Transplantation in Chinese Population
por: Jiang, Zhijun, et al.
Publicado: (2013)

MicroRNA‐761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin‐2
por: Zhou, Xiaohu, et al.
Publicado: (2016)

Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
por: Wang, Hangxiang, et al.
Publicado: (2018)

Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
por: Yan, Yingcai, et al.
Publicado: (2016)

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma
por: Wang, Jianguo, et al.
Publicado: (2020)

A Critical Role for ZDHHC2 in Metastasis and Recurrence in Human Hepatocellular Carcinoma
por: Peng, Chuanhui, et al.
Publicado: (2014)

IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice
por: YU, ZHIYONG, et al.
Publicado: (2015)

Epidermal Growth Factor Gene Polymorphism and Risk of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhong, Jian-Hong, et al.
Publicado: (2012)

Caspase polymorphisms and prognosis of hepatocellular carcinoma
por: Zhang, Song, et al.
Publicado: (2017)

Association of interleukin 16 gene polymorphisms and plasma IL16 level with osteosarcoma risk
por: Tang, Yu-Jin, et al.
Publicado: (2016)

Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
por: Ding, Jun, et al.
Publicado: (2018)

Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma
por: Xu, Xiao, et al.
Publicado: (2016)

Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
por: Yu, Xiaobo, et al.
Publicado: (2011)

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

HJURP Promotes Epithelial-to-Mesenchymal Transition via Upregulating SPHK1 in Hepatocellular Carcinoma
por: Chen, Tianchi, et al.
Publicado: (2019)

The association between EGF A61G polymorphism and risk of colorectal cancer in a Chinese population: a case-control study
por: Zhu, Xiaoying, et al.
Publicado: (2019)

Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma
por: Chen, Tianxiang, et al.
Publicado: (2012)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

CYR61/CCN1: A novel mediator of epidermal hyperplasia and inflammation in psoriasis?
por: Quan, Taihao, et al.
Publicado: (2015)

Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
por: Zheng, Qunhao, et al.
Publicado: (2021)

Experiments (16.3.61 and 25.3.61) concerning short target burst production using RF KO
por: Geiger, M, et al.
Publicado: (1961)

Cannot write session to /tmp/vufind_sessions/sess_1gnufl76m0lab8hl03t6gg188b